All In MedTech

FDA Clearance Tracker · P840024-S080

NUCLEUS 22 COCHLEAR IMPLANT SYSTEM- ADULTS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 16, 2001 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jan 16, 2001

Approved

Time to decision

48 days

Received Nov 29, 2000. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P840024-S080
Device name
NUCLEUS 22 COCHLEAR IMPLANT SYSTEM- ADULTS
Applicant location
Lone Tree, CO
Received
Nov 29, 2000
Decided
Jan 16, 2001
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P840024

Device type

Device class
Class III

Every decision under product code MCM

FDA's approval statement

As written in FDA's record.

APPROVAL FOR MODIFICATION TO THE FIRMWARE, COMPONENTS AND LABELING OF THE PORTABLE PROGRAMMING SYSTEM (PPS) WITH NO CHANGE TO THE CURRENTLY APPROVED INDICATIONS FOR USE.

Source documents

Other decisions for Cochlear Americas

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.